Head and Neck Research Studies
HN001: Randomized Phase II and Phase III Studies of Individualized for Nasopharyngeal Carcinoma Base on Biomarker Epstein Barr Virus (EBV) Deoxyriboncleic Acid (DNA).
NASAL & PARANASAL SINUS
EA3163: Phase II Randomized Trial of Neoadjuvant Chemotherapy followed by Surgery and Post-Operative Radiation Versus Surgery and Post-Operative Radiation for Organ Preservation of T3 and T4 Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)
EA3161: A Phase II/III Randomized Study of Maintenance Nivolumab Versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA
HN005: A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, p16-Positve, Non-Smoking Associated Oropharyngeal Cancer
HN004: Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin.
IDR-OM-02: A Pivotal, Double-Blind, Randomized, Placebo-Controlled, Multinational Study of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Patients Being Treated with Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck